不同链长聚乙二醇修饰的香豆素6脂质纳米粒对口服吸收的影响
Effects of polyethylene glycol length on oral absorption of coumarin 6-loaded nanostructured lipid carrier
-
摘要: 通过制备不同链长聚乙二醇（PEG）修饰的纳米脂质载体（NLCs）考察PEG链长对其口服吸收的影响。使用聚乙二醇（100）单硬脂酸酯（S100）、聚乙二醇（55）单硬脂酸酯（S55）、聚乙二醇（40）单硬脂酸酯（S40）3种不同链长的PEG通过薄膜分散法制备NLCs，以香豆素6 （coumarin 6）作为荧光探针，对修饰不同链长PEG的NLCs进行理化性质表征。考察了不同链长PEG修饰的NLCs在模拟缓冲液中的稳定性以及体外释药行为。同时对NLCs的细胞毒性、细胞摄取动力学以及摄取机制进行了考察。结果表明，随着PEG链段长度的增加，其水化层厚度不断增大。与其他NLCs相比，S100修饰的NLCs（pNLC-EG100）具有更好的细胞摄取效率，证明S100的链段长度是用于口服NLCs给药的最佳长度。Abstract: Polyethylene glycol (PEG) of different lengths were prepared to investigate their effects on oral absorption of nanostructured lipid carrier (NLCs).Three kinds of PEG-modified NLCs with different chain lengths, including polyethylene glycol (100) monostearate (S100), polyethylene glycol (55) monostearate (S55), polyethylene glycol (40) monostearate (S40), were prepared by film dispersion method.Coumarin 6 was chosen as a fluorescent probe to characterize the physicochemical properties of NLCs with different lengths.Meanwhile, the stability of NLCs in simulate buffer, the release behavior, cytotoxicity of NLCs, the uptake kinetics and cellular uptake mechanisms were evaluated. This work demonstrated that the thickness of the hydrated layer increased with the increase of PEG length. Of note, S100-modified NLCs (pNLC-EG100) exhibited higher cellular uptake efficiency compared with other formulations. Thus, S100 was optimized as the best molecular weight for PEG-modified NLCs on oral drug delivery system.
-
Keywords:
- nanostructured lipid carriers /
- PEG modification /
- coumarin 6 /
- PEG length /
- cell uptake /
- oral absorption
-
-
[1] . Pharmaceutics，2019，11（3）： E129 .[2] Date AA，Hanes J，Ensign LM. Nanoparticles for oral delivery：Design，evaluation and state-of-the-art［J］. J Control Release，2016，240：504-526. [3] Khosa A，Reddi S，Saha RN. Nanostructured lipid carriers for site-specific drug delivery［J］. Biomed Pharmacother，2018，103：598-613. [4] Garbuzenko OB，Kbah N，Kuzmov A，et al. Inhalation treatment of cystic fibrosis with lumacaftor and ivacaftor co-delivered by nanostructured lipid carriers［J］. J Control Release，2019，296：225-231. [5] Ensign LM，Cone R，Hanes J. Oral drug delivery with polymeric nanoparticles：the gastrointestinal mucus barriers［J］. Adv Drug Deliv Rev，2012，64（6）：557-570. [6] Takeuchi H，Yamamoto H，Niwa T，et al. Enteral absorption of insulin in rats from mucoadhesive chitosan-coated liposomes［J］. Pharm Res，1996，13（6）：896-901. [7] Alp G，Aydogan N. Lipid-based mucus penetrating nanoparticles and their biophysical interactions with pulmonary mucus layer［J］. Eur J Pharm Biopharm，2020，149：45-57. [8] Lai SK，Wang YY，Hanes J. Mucus-penetrating nanoparticles for drug and gene delivery to mucosal tissues［J］. Adv Drug Deliv Rev，2009，61（2）：158-171. [9] Huckaby JT，Lai SK. PEGylation for enhancing nanoparticle diffusion in mucus［J］. Adv Drug Deliv Rev，2018，124：125-139. [10] Tan XY，Zhang Y，Wang Q，et al. Cell-penetrating peptide together with PEG-modified mesostructured silica nanoparticles promotes mucous permeation and oral delivery of therapeutic proteins and peptides［J］. Biomater Sci，2019，7（7）：2934-2950. [11] Li HP，Su ZG，Chen ML，et al. Preparation and characterization of nanostructured lipid carriers with difference in particle size［J］. J China Pharm Univ（中国药科大学学报），2015，46（4）：436-443. [12] Sadzuka Y，Nakade A，Hirama R，et al. Effects of mixed polyethyleneglycol modification on fixed aqueous layer thickness and antitumor activity of doxorubicin containing liposome［J］. Int J Pharm，2002，238（1/2）：171-180. [13] Allard-Vannier E，Hervé-Aubert K，Kaaki K，et al. Folic acid-capped PEGylated magnetic nanoparticles enter cancer cells mostly via clathrin-dependent endocytosis［J］. Biochim Biophys Acta Gen Subj，2017，1861（6）：1578-1586. [14] Wang XY，Wang XY，Qiu LZ，et al. Cytotoxicity and cellular uptake of paclitaxel-loaded carboxymethyl chitosan-Rhein polymeric micelles in MCF-7 cells［J］. J China Pharm Univ（中国药科大学学报），2020，51（1）：33-37.
计量
- 文章访问数: 192
- HTML全文浏览量: 8
- PDF下载量: 627
下载:
